With nearly 58,000 doses of vaccine given since the last week of January, and invites now being sent out to those who are aged between 25 and 29, you would think staff at the VCC could be easing their foot off the pedal and looking to the end of Phase 2 of the programme in July.
The Policy & Resources Committee have agreed to continue the Payroll Co-Funding Scheme for an additional three months and have also announced the intention to launch a Visitor Attraction Support scheme.
The Payroll Co-Funding Scheme will now continue until the end of September 2021.
Following the recent advice issued by the JCVI that individuals aged between 18 and 39 should be offered an alternative vaccine to Astra Zeneca where possible, those in that age cohort living in Alderney have been contacted to discuss their options.
Anyone aged 40 or over is encouraged to make their vaccination appointments by Saturday 22 May. Those seeking to delay their appointment in order to be offered an alternative to the AstraZeneca vaccine should note that this cannot be guaranteed.
From 14 May, transiting through Southampton Airport or Poole and Portsmouth ferry ports will not affect the ‘category’ applied to travellers to the Bailiwick.
Public Health Services is asking individuals who were identified as a positive case of COVID-19 in the Bailiwick between September 2020 and March 2021 to complete a questionnaire about their experiences.
With one week to go until the introduction of ‘Category 2’ countries and regions as part of the Bailiwick’s travel rules, the CCA are advising those preparing to make a journey of some of the things they will need to consider.
With effect from 14 May 2021 travellers arriving in the Bailiwick from a category 2 country or region will be able to take a test on arrival and, subject to a negative result, will be in passive follow up until day 14 with an additional COVID-19 test on day 7.
The Bailiwick COVID-19 Vaccination Programme team is aware of the guidance published today by the Joint Committee on Vaccination and Immunisation (JCVI). The JCVI has stated that their preference is that individuals aged between 30 and 39 should be offered the Pfizer BioNTech or Moderna vaccine but the AstraZeneca vaccine can continue to be used for this age group.
As we move towards a further easing of border restrictions to include Category 2 countries and regions, Islanders are being asked to check that they are prepared for what their journey may require before they travel.
